ReElement Technologies & Exigo Battery Solutions Pvt. Ltd. Announce A Joint Venture For Rare Earth Magnet Recycling - Feedstocks of EV motors, HDDs, wind turbines, MRI machines, & other #rareearth -containing materials scaling to 2,000+ mt per annum $arec feeds.issuerdirect.com/news-release.h…

$ANRO - Alto Neuroscience Announces Acquisition Of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout In Treatment Resistant Depression Within Current Cash Runway for $1.75 Million Upfront, With $71.5 Million in Future Milestones.. Alto Neuroscience

$ANRO Alto Neuroscience acquires dopamine agonist combination candidate Alto Neuroscience entered into an asset purchase agreement with Chase Therapeutics for a portfolio of potentially best-in-class dopamine agonist drug combinations, including ALTO-207.

ReElement Technologies Corporation Receives $150 Million Letter of Interest from United States EXIM Bank to Advance the Nation's Largest Critical Mineral Refinery - Advanced Technology Center positioned to become the largest multi-mineral, multi-feedstock rare earth and critical

ReElement Technologies Corporation Receives $150 Million Letter of Interest from United States EXIM Bank to Advance the Nation's Largest Critical Mineral Refinery - Marion Advanced Technology Center positioned to become the largest multi-mineral, multi-feedstock rare earth and

Six months is less than we need to scale to the size of our defense dept!

action without vision equals chaos

It really is so simple… I don’t know why you don’t see it.

ICYMI, we were proud to join fellow leaders at #BIO2025 to discuss how precision medicine is redefining #psychiatry. Thank you to the organizers and everyone who attended our panel! ​ #PrecisionPsychiatry

$ANRO - Alto Neuroscience 🔹Identifies Biomarker 🔹Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203 👆 0% PreM/ $2.58

$ANRO Alto Neuroscience identifies biomarker, reports ALTO-203 pharmacodynamic results Alto Neuroscience announced the identification of a patient selection biomarker and pharmacodynamic results from its exploratory Phase 2 proof-of-concept trial of ALTO-203 in major depressive

$ANRO Alto Neuroscience finds biomarker & reports positive results from Phase 2 trial of ALTO-203. More Info: pryzm.ozmosi.com/product/27727 $XBI $IBB $XPH $PPH

We're excited to announce the identification of an #EEG biomarker and positive pharmacodynamic results from our exploratory Phase 2 proof-of-concept (POC) #ClinicalTrial of ALTO-203 in #MajorDepressiveDisorder patients with elevated levels of anhedonia. investors.altoneuroscience.com/news/news-deta…

We’re excited to highlight that data from the PAX-D study evaluating pramipexole in patients with treatment-resistant depression (TRD) were published online in The Lancet Psychiatry. Results from this study guided Alto’s acquisition of ALTO-207. Read more: investors.altoneuroscience.com/news/news-deta…

At $110k per KG of NdPr our margins are substantially higher than 70% from our West Virginia #rareearth reserve. Great day to be a low cost $AREC

I had the honor of interviewing Pastor John MacArthur on my show on a few different occassions. He's been a courageous voice for the gospel of Jesus Chris for much longer than I have been alive. The country and the Kingdom of God are better because this man devoted his life to

ODD NATION! We have made it amongst the Best Hobby Game #finalists for GDWC 2025 Summer Season! Follow along, we will be announcing our public Playtest very soon! thegdwc.com/awards/ #gameawards #indiegames #indiedevs #gamedev #Awards #award

🤝 - aligned in vision 🦄 - boundless in growth 🫂 - citizens of change 🧠 - join a real purpose, join Meet Nippy

GM!

🚨 Here is the full 42 minutes of my crew and I exposing Minnesota fraud, this might be my most important work yet. We uncovered over $110,000,000 in ONE day. Like it and share it around like wildfire! Its time to hold these corrupt politicians and fraudsters accountable We ALL